Showing results (141-150 of 586) with videos related to

Sort By:
Pageof 59
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|August 1, 1996
Methods of measuring susceptibility of anaerobic bacteria to trovafloxacin, including quality control parametersA L Barry, P C Fuchs, C Thornsberry, et al.
Diagnostic Microbiology and Infectious Disease|March 1, 1987
CI-934, a new difluoroquinolone: in vitro antibacterial activity and proposed disk diffusion test interpretive criteriaP C Fuchs, A L Barry, R N Jones, et al.
Journal of Clinical Microbiology|April 1, 1992
Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacinA L Barry, M A Cohen, J C Sesnie, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1980
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
The American Journal of Medicine|December 29, 1989
In vitro antimicrobial activity and susceptibility testing of ofloxacin. Current statusP C Fuchs
The American Journal of Medicine|December 30, 1991
In vitro activity of temafloxacin against gram-positive cocci including methicillin-resistant Staphylococcus aureusP C Fuchs
Journal of Clinical Microbiology|November 1, 1992
Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacinA L Barry, J H Jorgensen, D J Hardy, et al.
Diagnostic Microbiology and Infectious Disease|January 1, 1988
Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter studyP C Fuchs, R N Jones, A L Barry, et al.
European Journal of Epidemiology|November 1, 1993
In vitro activity of ceftriaxone and other cephalosporins against 602 clinical isolates of staphylococci from geographically diverse medical centersM A Pfaller, A L Barry, L D Sabath, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
In vitro activity of FCE 22101, imipenem, and ceftazidime against over 6,000 bacterial isolates and MIC quality control limits of FCE 22101A L Barry, K E Aldridge, S D Allen, et al.
Pageof 59